國立虎尾科技大學 |

Development and Validation of the Human Rosette Array for Neural Tube Defect Risk Screening.

紀錄類型:	書目-語言資料,手稿 : Monograph/item
正題名/作者:	Development and Validation of the Human Rosette Array for Neural Tube Defect Risk Screening./
作者:	Lundin, Brady F.
面頁冊數:	1 online resource (98 pages)
附註:	Source: Dissertations Abstracts International, Volume: 85-11, Section: B.
Contained By:	Dissertations Abstracts International85-11B.
標題:	Bioengineering. -
電子資源:	click for full text (PQDT)
ISBN:	9798382404998

Development and Validation of the Human Rosette Array for Neural Tube Defect Risk Screening.
Lundin, Brady F.

Development and Validation of the Human Rosette Array for Neural Tube Defect Risk Screening. - 1 online resource (98 pages)

Source: Dissertations Abstracts International, Volume: 85-11, Section: B.

Thesis (Ph.D.)--The University of Wisconsin - Madison, 2024.

Includes bibliographical references

Neural tube defects are the second most common congenital malformation and inflict significant morbidity and mortality upon affected patients. The mechanisms by with they form are unclear and traditional methods of studying the nascent central nervous system have significant limitations. Neural organoids have revolutionized how human neurodevelopmental disorders are studied. Yet, their utility for screening complex neural tube defect etiologies and potential prophylactics is limited by a lack of scalable and quantifiable derivation formats. Here, a brief introduction to neural tube formation and an overview of the known causes of neural tube defects is presented. Then a survey of the rapidly developing field of neural organoids is provided. After which, we describe the Rosette Array platform's ability to be used as an off-the-shelf, 96-well plate assay that standardizes incipient forebrain and spinal cord organoid morphogenesis as micropatterned, 3-D, singularly polarized neural rosette tissues. Rosette Arrays are seeded from cryopreserved human pluripotent stem cells, cultured over 6-8 days, and immunostained images can be quantified using artificial intelligence-based software. We demonstrate the platform's suitability for screening genetic and environmental factors known to cause neural tube defect risk. Lastly, the discussion closes by considering the implications of the platform's development and screening results and future research directions regarding understanding and preventing neural tube defect formation.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2024

Mode of access: World Wide Web

ISBN: 9798382404998Subjects--Topical Terms:

598252
Bioengineering.
Subjects--Index Terms:

Disease modelingIndex Terms--Genre/Form:

554714
Electronic books.

Development and Validation of the Human Rosette Array for Neural Tube Defect Risk Screening.
LDR:03042ntm a22004337 4500 001 1151912
005 20241118135905.5
006 m o d
007 cr mn ---uuuuu
008 250605s2024 xx obm 000 0 eng d
020 $a 9798382404998
035 $a (MiAaPQ)AAI31239092
035 $a AAI31239092
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Lundin, Brady F. $3 1478754
245 1 0 $a Development and Validation of the Human Rosette Array for Neural Tube Defect Risk Screening.
264 0 $c 2024
300 $a 1 online resource (98 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 85-11, Section: B.
500 $a Advisor: Ashton, Randolph S.
502 $a Thesis (Ph.D.)--The University of Wisconsin - Madison, 2024.
504 $a Includes bibliographical references
520 $a Neural tube defects are the second most common congenital malformation and inflict significant morbidity and mortality upon affected patients. The mechanisms by with they form are unclear and traditional methods of studying the nascent central nervous system have significant limitations. Neural organoids have revolutionized how human neurodevelopmental disorders are studied. Yet, their utility for screening complex neural tube defect etiologies and potential prophylactics is limited by a lack of scalable and quantifiable derivation formats. Here, a brief introduction to neural tube formation and an overview of the known causes of neural tube defects is presented. Then a survey of the rapidly developing field of neural organoids is provided. After which, we describe the Rosette Array platform's ability to be used as an off-the-shelf, 96-well plate assay that standardizes incipient forebrain and spinal cord organoid morphogenesis as micropatterned, 3-D, singularly polarized neural rosette tissues. Rosette Arrays are seeded from cryopreserved human pluripotent stem cells, cultured over 6-8 days, and immunostained images can be quantified using artificial intelligence-based software. We demonstrate the platform's suitability for screening genetic and environmental factors known to cause neural tube defect risk. Lastly, the discussion closes by considering the implications of the platform's development and screening results and future research directions regarding understanding and preventing neural tube defect formation.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2024
538 $a Mode of access: World Wide Web
650 4 $a Bioengineering. $3 598252
650 4 $a Neurosciences. $3 593561
650 4 $a Developmental biology. $3 669036
650 4 $a Biomedical engineering. $3 588770
650 4 $a Immunology. $3 592892
653 $a Disease modeling
653 $a Human pluripotent stem cell
653 $a Neural development
653 $a Neural rosettes
653 $a Neural tube defects
653 $a Tissue engineering
655 7 $a Electronic books. $2 local $3 554714
690 $a 0202
690 $a 0317
690 $a 0758
690 $a 0541
690 $a 0982
710 2 $a ProQuest Information and Learning Co. $3 1178819
710 2 $a The University of Wisconsin - Madison. $b Biomedical Engineering. $3 1478755
773 0 $t Dissertations Abstracts International $g 85-11B.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31239092 $z click for full text (PQDT)